POAI: Predictive Oncology Long-Term Debt Volume

Graphic logo of Predictive Oncology Inc (POAI)

The market trend for the long-term liabilities of Predictive Oncology (POAI), which stands at 0.00, is accompanied by the implementation of green IT solutions to combat cancer and minimize server costs. Predictive Oncology relies on digital modeling that reduces the number of physical chemical tests and the volume of biohazardous waste. The business is based on the expansion of PeDAL software, which aims to capture the high-precision therapy forecasting market through B2B subscriptions.

POAI Predictive Oncology Inc: Company Long-Term Debts in the range 07/04/2022 - 12/12/2025

Analytical breakdowns for Predictive Oncology

- price and consensus price forecast:
Share Price Predictive Oncology Inc|POAI - Analyst Consensus Forecast
- market capitalization data:
Market Capitalization Predictive Oncology|POAI - Enterprise Value
- book capitalization data:
Accounting Value per Share Predictive Oncology|POAI - Book Capitalization|Market Capitalization to Book Value Ratio predictive-oncology.com|POAI - Aggregate Company Assets
- debt and liquidity data:
Debt to Equity Predictive Oncology|POAI - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Predictive Oncology Inc|POAI - Company Aggregate Debts|Debts to Net Assets Predictive Oncology|POAI - Company Long-Term Debt|Company Short-Term Indebtedness Predictive Oncology
General company analysis:Predictive Oncology (POAI)
Mass-produced product of Predictive Oncology Corp

This indicator captures the total volume of long-term liabilities, reflecting the dynamics of borrowed capital and the degree of business financial autonomy during long-term planning. Rising debt loads, coupled with the limited pricing power of Predictive Oncology (POAI) in the AI analytics segment, increase liquidity risks, allowing for an assessment of the company's stability through the current level of the enterprise's long-term debt.

Competitor analysis

Company Long-Term Indebtedness intuitive.com ISRG|Company Long-Term Debts DHR (Danaher)|BDX - Long-Term Debt Volume|STE (STERIS Corporation) - Company Long-Term Debts|West Pharma Corp (WST) - Company Long-Term Liabilities|BAX (Baxter International) - Company Long-Term Debts|Company Long-Term Debts MASI|Company Long-Term Debt Stevanato Group (STVN)|Company Long-Term Debt Teleflex Inc. TFX|Company Long-Term Liabilities Merit Medical Systems Inc|Company Long-Term Loans and Borrowings Nobel Biocare NVST|Company Long-Term Debts ICUI (ICU Medical, Inc.)|XRAY: Long-Term Debt Volume|Company Long-Term Debt LeMaitre Vascular|ATRC (AtriCure Inc) - Company Long-Term Indebtedness|STAA: Company Long-Term Debt|Long-Term Debt Volume niagenbioscience.com (NAGE)|Company Long-Term Liabilities ZimVie Inc.|Amount of Long-Term Liabilities ANGO (angiodynamics.com)|Company Long-Term Debt Cerus|TKNO - Company Long-Term Loans and Borrowings|Monogram Technologies Inc - Company Long-Term Liabilities|STSS: Company Long-Term Debts|INFU (infusystem.com) - Company Long-Term Debt|utahmed.com (UTMD) - Company Long-Term Liabilities|Company Long-Term Debts KRMD (KORU Medical Systems, Inc.)|Long-Term Debt NYXH|Company Long-Term Debt Microbot Medical Inc MBOT|Company Long-Term Indebtedness Pro-Dex Inc. PDEX|Company Long-Term Liabilities Zentek Ltd. (ZTEK)|elutia.com - Amount of Long-Term Liabilities|Company Long-Term Debt MLSS (Milestone Scientific Inc.)|NXGL: Long-Term Debt Volume|Company Long-Term Debt retractable.com (RVP)|HBIO (Harvard Bioscience Inc.) - Long-Term Liabilities|FEMY - Company Long-Term Debt|Company Long-Term Loans and Borrowings Meihua Medical|Callan JMB Inc - Company Long-Term Debts|Long-Term Debt Atrion Corp. (ATRI)|NURO - Company Long-Term Debts